Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
| Image |  |
|---|---|
| Description | scientific article published on 15 February 2019 |
| Author/s |
author: Matthew D Hellmann Emiliano Calvo F Stephen Hodi Yung-Jue Bang Andrés Cervantes |
| Publication date | February 15, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |